510(k) K023592
K023592 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "SERAQUEST ANTI-THYROGLOBULIN". The FDA issued a decision of Substantially Equivalent on Jan 6, 2003. The device falls under product code DDC (Thyroglobulin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5870. Quest Intl., Inc. has 24 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 6, 2003
- Date Received
- Oct 25, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Thyroglobulin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5870
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Quest Intl., Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.